Evidence map›Paper›PMID 35719741›Full record

ArticleACS catalysis2022

Engineered Tryptophan Synthase Balances Equilibrium Effects and Fast Dynamic Effects.

Joseph W Schafer, Xi Chen, Steven D Schwartz

Abstract read
In one paragraph

Article in ACS catalysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joseph W SchaferDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan 48109, United States.
Xi ChenDepartment of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.ORCID 0000-0002-6378-4557
Steven D SchwartzDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-0308-1059

Funding

Rapid protein dynamics and catalysis: modulation by laboratory evolution, designed mutation, and protein control of electric field environmentR01GM127594 · NIGMS · UNIVERSITY OF ARIZONA · PI SCHWARTZ, STEVEN D · 2019 to 2022
$1.4M
NIGMS NIH HHS R01 GM127594
6 · The paper itself

Abstract

Creating efficient and stable enzymes for catalysis in pharmaceutical and industrial laboratories is an important research goal. Arnold et al. used directed evolution to engineer a natural tryptophan synthase to create a mutant that is operable under laboratory conditions without the need for a natural allosteric effector. The use of directed evolution allows researchers to improve enzymes without understanding the structure-activity relationship. Here, we present a transition path sampling study of a key chemical transformation in the tryptophan synthase catalytic cycle. We observed that while directed evolution does mimic the natural allosteric effect from a stability perspective, fast protein dynamics associated with chemistry has been dramatically altered. This work provides further evidence of the role of protein dynamics in catalysis and clearly demonstrates the multifaceted complexity of mutations associated with protein engineering. This study also demonstrates a fascinating contrast between allosteric and stand-alone functions at the femtosecond time scale.

Indexed as

allosteric effectcomputational chemistrydirected evolutionMarkov chain Monte Carlopromoting vibration

Identifiers

PMID35719741
PMCPMC9202816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.